Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Bone Neoplasms × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Genitourinary 1

Conditions

Vasculitis 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Metabolic Syndrome 1 Lung Neoplasms 1 Inflammation 1 Granulomatosis with Polyangiitis 1 Bone Neoplasms 1 Arthritis, Juvenile 1

Interventions

Methotrexate 1 Grafton demineralized bone matrix gel 1 Exercise Therapy 1 Etanercept 1 Doxorubicin 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00127387 2012-06-26

Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

The University of Texas Health Science Center at San Antonio

Phase 2/3 Terminated

GenitourinarySarcomaThoracic

Bone Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡